From: Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study
Group subtype
Durie-Salmon staging
ISS staging
IIIA
IIIB
I
II
III
Velcade group(n = 66)
36
30
9
17
40
Without Velcade group(n = 30)
24
6
3
18
Total
60
12
26
58